Who are Xellia's investors?

Xellia's investors include 3i Group.

Xellia

1 known investors

Xellia is a manufacturer of fermentation-based non-beta-lactam anti-infective medicines, supplying active pharmaceutical ingredients (APIs) and finished dosage forms to pharmaceutical companies. It serves more than 500 pharmaceutical companies across 80 countries, operating EU-based production as one of the last Western manufacturers of several essential anti-infective APIs.

Advanced Manufacturing Biotech Healthtech

Founders & leadership

Michael KocherCEO

Alexander SproedtChief Operations Officer

Gael BernardChief Commercial Officer

Vicente OllerChief Financial Officer

Art FioccoChief Quality Officer

Linda Haugaard-KedströmChief Scientific Officer

Investors · 1

3i GroupLondon

In the news

Antibiotics specialist Xellia plots 247 layoffs on the heels of Ohio plant sale to Hikma | Fierce Pharmafiercepharma.com · Jun 2024

Xellia spent $200M and 5 years to fix up former Boehringer site in Cleveland. Now, it's up and running again | Fierce Pharmafiercepharma.com · Aug 2021

Xellia Pharmaceuticals secures $430m financing to support long-term growthxellia.com

Frequently asked questions

What does Xellia do?: Xellia is a manufacturer of fermentation-based non-beta-lactam anti-infective medicines, supplying active pharmaceutical ingredients (APIs) and finished dosage forms to pharmaceutical companies. It serves more than 500 pharmaceutical companies across 80 countries, operating EU-based production as one of the last Western manufacturers of several essential anti-infective APIs.
Who are Xellia's investors?: Xellia's investors include 3i Group.